Michael Froehler

New research indicates the time window for a thrombectomy following a stroke is longer than previously thought, but how soon the surgery occurs still matters. Read More

Vanderbilt University Medical Center’s (VUMC) rapid response in treating stroke patients has received the American Stroke Association’s Honor Roll-Elite Plus recognition for the third consecutive year. Read More

The Vanderbilt Stroke Center will participate in a national clinical trial to investigate whether thrombectomies can benefit stroke patients when performed beyond the currently recommended window of time for intervention. Read More

For nearly a decade, Vanderbilt University Medical Center has been at the forefront of stroke treatment using endovascular neuro-interventional techniques. Similar to procedures done for a heart attack, interventional stroke treatment employs suction and retrievers to remove blood clots. Read More

Conventional therapy for patients diagnosed with retinoblastoma, the most common ocular cancer in children, includes systemic chemotherapy, external beam radiation and/or surgical removal of the eye. Doctors at Vanderbilt University Medical Center are on track to radically change the way the disease is treated using an emerging therapeutic approach called intra-arterial chemotherapy, or IA chemo. Read More

A new advanced stroke treatment suite debuts this month at Vanderbilt University Medical Center, offering better care for patients with blood circulation problems in the head and neck, such as stroke and aneurysm. Read More

Vanderbilt University Medical Center has joined a national network funded by the National Institutes of Health to streamline multi-site clinical trials focused on key interventions in stroke prevention, treatment and recovery. Read More